Wellington Management Group LLP Satsuma Pharmaceuticals, Inc. Transaction History

Wellington Management Group LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$3.85 - $28.47 $6.2 Million - $45.8 Million	-1,609,205 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$16.01 - $34.69 $7.53 Million - $16.3 Million	-470,301 Reduced 22.62%	1,609,205 $46.3 Million
Q1 2020 May 14, 2020	SELL	$14.53 - $30.69 $3.8 Million - $8.03 Million	-261,705 Reduced 11.18%	2,079,506 $44.8 Million
Q4 2019 Feb 11, 2020	BUY	$9.32 - $19.68 $21.8 Million - $46.1 Million	2,341,211 New	2,341,211 $45.7 Million

Ticker STSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,587,500
Description
Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company's lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in SUMMIT Phase 3 efficacy trials and can ...

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

Stay updated on Wellington Management Group LLP with notifications on news.